Which Results From ESMO 2026 Could Change How We Treat Melanoma and Skin Cancers? / ADCs, ADMEC-O, Andrea Boutros, ...
Randall Kimple Highlights the Teamwork Behind Cancer Research / cancer, NCI, OncoDaily, Oncology, Randall Kimple, University ...
Rachel Purcell Highlights New Zealand's Nationwide Exercise Program for Bowel Cancer Patients / bowel cancer, Bowel Cancer ...
Ginny Mason Reflecting on Importance of BCRF's Devoting $23.8 Million Across 102 Projects to MBC / BCRF, BCRF Ventures, ...
A Simple Act of Kindness and Commitment That Shows Up With the Same Care in Your Work” – Mina Sedrak, Director of the UCLA ...
Congratulations to Dana Pe’er and Ross Levine on Being Elected to the National Academy of Medicine - MSK / cancer, Dana Pe’er ...
Global Colon Cancer Association shared on LinkedIn: “15 days left to register for the 2026 Global CRC Congress. Virtual ...
European Liver Patients’ Association (ELPA), shared on LinkedIn: “From Patient Voice to Meaningful Evidence: Different ...
"Breaking the bureaucracy at WHO. Mechanism one: no empty desks" - Dr Gevorg Tamamyan / cancer, Gevorg Tamamyan, global ...
Exploring the Role of AI in Cancer Detection and Treatment / AI in oncology, Alicia Fong, artificial intelligence, cancer, ...
Supporting Breast Cancer Awareness at the Race for the Cure / breast cancer awareness, cancer, David Heathcote, Dina De Haeck ...
Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease
A 2026 review maps targeted therapy across EGFR, ALK, ROS1, KRAS, MET, RET and other NSCLC drivers, including resistance and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results